Indian Tadalafil Brands: Products, Manufacturers & Market Context

Major Indian Tadalafil Brands at a Glance

The table below focuses on single-ingredient tadalafil products with identifiable brand and company relationships. The strength column lists documented product presentations rather than recommending a dose, and availability can change over time or differ between markets.

Where a brand family contains unusual higher-strength or specialty products, inclusion means that a presentation has been documented in manufacturer, regulatory or market records. It does not mean that the strength matches standard CIALIS labeling or carries identical regulatory status in another country.

How to Interpret an Indian Tadalafil Brand List

A tadalafil brand list combines several different types of information: the active pharmaceutical ingredient, the brand or trade name, the company associated with the product, strength, dosage form and the jurisdiction in which a presentation is marketed or registered. Those attributes should not be collapsed into a single assumption about equivalence.

For example, two tablets can both contain tadalafil 20 mg while carrying different brands, excipients, packaging, marketers and regulatory histories. Conversely, products that share a brand-family name can contain different strengths or even additional active ingredients.

For that reason, the most reliable way to identify a product is to read the complete composition and manufacturer or marketer information rather than relying on the brand name alone.

Tadacip: Cipla's Documented Tadalafil Brand

Cipla's current generic product catalog lists TADACIP 20 with tadalafil 20 mg in tablet form. This provides a direct company-source connection between the Tadacip name, Cipla and the documented 20 mg tadalafil presentation.

The Tadacip identity should still be separated from the broader concept of Cipla as a manufacturer and from tadalafil products marketed by other companies. The dedicated Tadacip page handles the finished-product relationship in more detail.

Forzest and Modula: Two Sun Pharma Tadalafil Brands

Sun Pharma's current India product catalog documents more than one pure-tadalafil brand. FORZEST is listed as a 20 mg tadalafil tablet, while MODULA is listed as a 5 mg tadalafil tablet.

This is a useful example of why a manufacturer-level list and a brand-level list serve different purposes. The same company can maintain multiple tadalafil brands with different strength positioning, so the product name remains relevant even when the active ingredient and company overlap.

Brand-specific context is available on Forzest and Modula.

Tazzle: Dr. Reddy's Tadalafil Brand

Tazzle is associated with Dr. Reddy's Laboratories and is documented in multiple tadalafil tablet strengths. Indian market and public product records identify 5 mg, 10 mg and 20 mg Tazzle presentations, with current pharmacy listings continuing to identify Dr. Reddy's as the company behind the brand.

The brand should not be confused with Dr. Reddy's separately marketed generic tadalafil products in other countries. A company can sell tadalafil under a domestic brand while also marketing differently labeled generic products in regulated export markets.

The specific product family is covered on the Tazzle page.

Filda and Megalis: Intas and Macleods Product Context

Intas Pharmaceuticals currently lists FILDA with tadalafil 20 mg in its own product catalog, providing a direct primary-source link between the Filda brand, Intas and the 20 mg strength. Macleods' Megalis brand is documented in Indian and regulatory product records in multiple strengths, including 5 mg, 10 mg and 20 mg tablets.

These examples also show why documented strengths should be treated as brand facts rather than universal dosing instructions. A product may exist in several strengths even though the appropriate tadalafil regimen depends on indication, labeling and individual clinical circumstances.

The product-level pages are Filda and Megalis.

Tadarise Has a Broad Manufacturer-Listed Product Family

Sunrise Remedies lists Tadarise as a tadalafil brand and documents tablet strengths of 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg and 60 mg. The company also markets specialty tadalafil-only presentations under the Tadarise name, including a 20 mg oral jelly and an effervescent formulation.

The wide range is a product-catalog fact, not a statement that every listed strength corresponds to standard tadalafil labeling in another jurisdiction. Higher-strength export-oriented products need especially careful separation from U.S. or European product labeling.

The pure-product family and its naming structure are examined separately on the Tadarise page.

Vidalista Has Multiple Documented Tadalafil Strengths

Vidalista is associated with Centurion Laboratories and has been documented in a wide range of tadalafil tablet strengths. Records and market listings include 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg and 60 mg presentations, with additional higher-strength and specialty variants also appearing in external records.

The existence of a marketed strength should not be confused with approval in every jurisdiction. In particular, a foreign-market brand presentation is not automatically equivalent to an FDA-approved generic tadalafil product merely because the active ingredient and nominal strength match.

The brand-specific evidence, strength claims and regulatory distinctions belong on the Vidalista page.

Tadafil: Ajanta Pharma Tadalafil Product Context

Current Indian medicine listings identify Tadafil tablets containing tadalafil and associate the brand with Ajanta Pharma. Both 10 mg and 20 mg presentations can be documented in current Indian market sources, with the 20 mg product being a prominent brand-strength pairing.

Ajanta Pharma is also associated with other tadalafil names in different markets, which reinforces the need to distinguish company identity from brand identity. Tadafil should therefore be treated as one product family rather than as a synonym for every Ajanta tadalafil product.

The dedicated Tadafil page covers that relationship without turning this hub into a manufacturer profile.

Pure Tadalafil Brands Should Be Separated From Combination Products

Some Indian brand families use similar names for both single-ingredient tadalafil products and tablets containing tadalafil plus another active drug. Those products should not be merged into a single strength list because the composition, safety profile and therapeutic intent are no longer the same.

Sunrise Remedies provides a clear example. Standard Tadarise products contain tadalafil alone, while Top Tadarise, Super Tadarise and Extra Super Tadarise are documented combinations of tadalafil with dapoxetine in different amounts.

For this reason, combination variants are excluded from the pure-tadalafil master table above even when they share part of the same commercial brand name.

What Does 'Indian Branded Generic Tadalafil' Mean?

In practical market language, an Indian branded generic is a product sold under a company-specific trade name while containing an established active ingredient such as tadalafil. Tadacip, Forzest, Filda and similar names therefore identify commercial products rather than new active molecules.

The phrase should not be used to imply automatic therapeutic equivalence across jurisdictions. In the United States, for example, FDA therapeutic-equivalence status depends on an approved application and the applicable reference-listed drug framework; an imported brand name by itself does not establish that status.

For a broader explanation of active ingredient, branded products and regulatory equivalence, see generic tadalafil.

Brand Research and Manufacturer Research Are Different

A tadalafil brand page asks what a named product contains, which strengths are documented and which company is associated with it. A manufacturer page asks a different set of questions: company identity, manufacturing footprint, regulatory history, facilities and the wider tadalafil portfolio.

Keeping those intents separate prevents a brand hub from becoming a collection of corporate profiles. Readers who want to compare Cipla, Sun Pharma, Dr. Reddy's, Intas, Macleods, Ajanta and other companies should continue to tadalafil manufacturers in India.

This page therefore names companies only where that relationship helps establish the identity of a tadalafil brand.

Documented Brand Strengths Are Not Dosing Recommendations

The Indian tadalafil market includes familiar strengths such as 5 mg, 10 mg and 20 mg as well as products documented at 2.5 mg and higher strengths such as 40 mg or 60 mg. That range reflects product catalogs and market presentations, not a single recommended dosing ladder.

Tadalafil dose and schedule depend on indication, product labeling, other medicines, organ function and clinical judgment. A higher number on an export-market box should not be interpreted as evidence that the product is more appropriate, more effective or interchangeable with a lower-strength regulated product.

Dose selection itself belongs on the tadalafil dosage guide; this page uses strength only as a product-identification attribute.

How Brand, Company and Strength Claims Should Be Verified

Indian tadalafil brand research is more reliable when product claims can be traced to a manufacturer catalog, official company product list, regulatory or public-sector record, or a current established pharmacy listing that identifies both composition and marketer. Anonymous export-shop pages are a weaker basis for establishing product identity.

Primary sources are especially useful for brands such as Tadacip, Forzest, Modula, Filda and Tadarise because the relevant companies currently publish product information directly. Where primary manufacturer documentation is limited or difficult to retrieve, multiple independent records should agree before a strength or company relationship is treated as established.

The master table is therefore best read as a documented product map rather than as an exhaustive list of every tadalafil box ever offered in India.

Indian Market Presence Does Not Equal Approval Everywhere

Tadalafil brands marketed or manufactured in India can have a different regulatory status elsewhere. A product documented in India may be unregistered, unavailable or subject to different prescription and import rules in another country.

This distinction is particularly important when a brand name resembles a generic alternative to Cialis. Product identity, manufacturing origin and nominal tadalafil content are separate questions from whether a national regulator has approved that exact finished product.

The purpose of this directory is therefore informational: to map brands to documented companies, strengths and formulations rather than to identify cross-border purchasing routes.

Common Misunderstandings About Indian Tadalafil Brands

Indian tadalafil brands are sometimes treated as if they were one interchangeable category. In reality, the names belong to different companies, product families and documented strength ranges, and some related brand variants contain more than tadalafil alone.

Another common mistake is to treat every product described online as an approved generic equivalent of Cialis. A tadalafil ingredient claim and matching milligram strength do not by themselves establish regulatory approval, bioequivalence or therapeutic-equivalence status in a particular country.

Finally, a long list of brands should not be read as a recommendation to choose among them without clinical or pharmacy verification. The useful role of a brand directory is product identification and market context.

Key Takeaways: Indian Tadalafil Brands

India's tadalafil market includes multiple named products associated with major and specialist pharmaceutical companies. Tadacip is linked to Cipla, Forzest and Modula to Sun Pharma, Tazzle to Dr. Reddy's, Filda to Intas, Megalis to Macleods, Tadarise to Sunrise Remedies, Vidalista to Centurion Laboratories and Tadafil to Ajanta Pharma.

These brands do not all have the same documented strength range. Some are strongly associated with a single presentation such as Tadacip 20 mg, Forzest 20 mg, Modula 5 mg or Filda 20 mg, while families such as Tadarise and Vidalista appear in substantially broader ranges.

Brand, active ingredient, strength, dosage form, company and regulatory status should be evaluated as separate product attributes. Pure tadalafil products should also be distinguished from combination variants, and market presence in India should never be treated as automatic proof of approval or therapeutic equivalence in another jurisdiction.